slotkoers
Korea S.E.
00:00:00 14-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
10.670
KRW
|
-1,57%
|
|
-5,58%
|
-9,35%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
396.059
|
260.969
|
325.444
|
245.618
|
236.407
|
180.683
|
Bedrijfswaarde
1 |
466.703
|
353.452
|
445.276
|
313.466
|
345.621
|
335.694
|
K/w-verhouding
|
18,9
x
|
-2,88
x
|
28,5
x
|
-70,5
x
|
-3,17
x
|
-11,1
x
|
Dividendrendement
|
0,27%
|
0,41%
|
0,33%
|
0,41%
|
0,32%
|
0,42%
|
Marktkapitalisatie/omzet
|
2,77
x
|
0,36
x
|
0,43
x
|
0,32
x
|
0,3
x
|
0,22
x
|
Bedrijfswaarde/omzet
|
3,27
x
|
0,48
x
|
0,58
x
|
0,41
x
|
0,44
x
|
0,42
x
|
Bedrijfswaarde/EBITDA
|
37
x
|
21,6
x
|
14,5
x
|
37.729
x
|
103
x
|
10
x
|
Bedrijfswaarde/FCF
|
-3,34
x
|
123
x
|
-16,7
x
|
39,9
x
|
-17,1
x
|
-16,9
x
|
FCF Yield
|
-30%
|
0,81%
|
-5,99%
|
2,51%
|
-5,85%
|
-5,92%
|
Price to Book
|
0,81
x
|
0,66
x
|
0,8
x
|
0,6
x
|
0,7
x
|
0,57
x
|
Aantal aandelen (in duizenden)
|
15.351
|
15.351
|
15.351
|
15.351
|
15.351
|
15.351
|
Referentieprijs
2 |
25.800
|
17.000
|
21.200
|
16.000
|
15.400
|
11.770
|
Datum van publicatie
|
13/03/19
|
17/03/20
|
15/03/21
|
15/03/22
|
16/03/23
|
12/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
142.736
|
731.140
|
761.997
|
762.568
|
792.965
|
804.043
|
EBITDA
1 |
12.608
|
16.389
|
30.654
|
8,308
|
3.357
|
33.476
|
Bedrijfsresultaat (EBIT)
1 |
10.949
|
8.607
|
22.003
|
-8.975
|
-7.548
|
20.920
|
Operationele Marge
|
7,67%
|
1,18%
|
2,89%
|
-1,18%
|
-0,95%
|
2,6%
|
Resultaat voor belastingen (EBT)
1 |
9.788
|
-82.600
|
30.822
|
-6.129
|
-83.861
|
-13.982
|
Nettowinst (verlies)
1 |
7.070
|
-90.661
|
11.431
|
-3.482
|
-74.556
|
-16.250
|
Nettomarge
|
4,95%
|
-12,4%
|
1,5%
|
-0,46%
|
-9,4%
|
-2,02%
|
WPA
2 |
1.363
|
-5.906
|
744,6
|
-227,0
|
-4.857
|
-1.059
|
Free Cash Flow
1 |
-139.801
|
2.880
|
-26.675
|
7.866
|
-20.230
|
-19.889
|
FCF-marge
|
-97,94%
|
0,39%
|
-3,5%
|
1,03%
|
-2,55%
|
-2,47%
|
Kasstroomconversie (ebitda)
|
-
|
17,57%
|
-
|
94.673,82%
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
70,00
|
70,00
|
70,00
|
65,00
|
50,00
|
50,00
|
Datum van publicatie
|
13/03/19
|
17/03/20
|
15/03/21
|
15/03/22
|
16/03/23
|
12/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
70.644
|
92.483
|
119.832
|
67.848
|
109.213
|
155.012
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
5,603
x
|
5,643
x
|
3,909
x
|
8.166
x
|
32,53
x
|
4,63
x
|
Free Cash Flow
1 |
-139.801
|
2.880
|
-26.675
|
7.866
|
-20.230
|
-19.889
|
ROE (netto-inkomsten/eigen vermogen)
|
1,83%
|
-17,9%
|
3,05%
|
-2,58%
|
-18,1%
|
-3,22%
|
ROA (netto-inkomsten/totale activa)
|
1,18%
|
0,61%
|
1,59%
|
-0,63%
|
-0,54%
|
1,5%
|
Totale activa
1 |
601.392
|
-14.886.805
|
720.162
|
552.501
|
13.894.099
|
-1.084.763
|
Nettoactief per aandeel
2 |
31.941
|
25.632
|
26.542
|
26.821
|
22.003
|
20.810
|
Cashflow per aandeel
2 |
2.677
|
1.383
|
1.315
|
1.862
|
2.264
|
2.413
|
Capex
1 |
50.199
|
37.686
|
9.811
|
23.688
|
15.462
|
6.223
|
Capex/omzet
|
35,17%
|
5,15%
|
1,29%
|
3,11%
|
1,95%
|
0,77%
|
Datum van publicatie
|
13/03/19
|
17/03/20
|
15/03/21
|
15/03/22
|
16/03/23
|
12/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -9,35% | 120 mln. | | +21,28% | 44,4 mld. | | +24,47% | 23,03 mld. | | +19,22% | 15,14 mld. | | +12,87% | 13,12 mld. | | +44,67% | 11,85 mld. | | -9,92% | 6,99 mld. | | -0,05% | 6,79 mld. | | -8,87% | 5,73 mld. | | +13,07% | 5,52 mld. |
Generieke geneesmiddelen
|